Cardiac involvement in thalassemia intermedia: A multicenter study

Blood

Volumn 97, Issue 11, 2001, Pages 3411-3416

  Aessopos, Athanasios ^a,b,c   Farmakis, Dimitrios ^a,b   Karagiorga, Markisia ^a,b   Voskaridou, Ersi ^a,b   Loutradi, Aphrodite ^a,b   Hatziliami, Antonia ^a,b   Joussef, Jacqueline ^a,b   Rombos, John ^a,b   Loukopoulos, Dimitris ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN;

ADULT; ANAMNESIS; AORTA VALVE REGURGITATION; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL EXAMINATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTILITY; HEART OUTPUT; HUMAN; HYPOXEMIA; LUNG CAPILLARY PRESSURE; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY;

EID: 0035383809     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3411     Document Type: Article

References (44)

1. Modell B, Berdoukas V. The Clinical Approach to Thalassemia. New York, NY: Grune & Stratton; 1984.
2. Zurlo MG, De Stefano P, Borgna-Pignatti C. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27-30.
3. Ehlers KH, Levin AR, Markenson AL, et al. Longitudinal study of cardiac function in thalassemia major. Ann N Y Acad Sci. 1980;344:397-404.
4. Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G, Mantzourani M, Loucopoulos D. Pulmonary hypertension and right heart failure in patients with β-thalassemia intermedia. Chest. 1995;107:50-53.
5. Klinkhoff AV, Thompson CR, Reid GD, Tomlinson CW. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA. 1985;253:3273-3277.
6. Feigenbaum H. Pericardial disease. In: Feigenbaum H, ed. Echocardiography. 5th ed. Philadelphia, PA: Lea & Febiger; 1994:556-561.
7. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75:175-183.
8. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol. 1992;19:1516-1521.
9. Levine RA, Stathoglannis E, Newell JB, Harrigan P, Weyman AE. Reconsideration of echocardiographic standards, for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four-chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988;11:1010-1019.
10. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
11. Feigenbaum H. Echocardiographic evaluation of cardiac chambers. In: Feigenbaum H, ed. Echocardiography. 5th ed. Philadelphia, PA: Lea & Febiger; 1994:134-173.
12. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee. J Am Soc Echocardiogr. 1989;2:358-367.
14. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol. 1996;27:1753-1760.
15. Andren B, Lind L, Hedenstierna G, Lithell H. Left ventricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J. 1996;17:1800-1807.
16. Dabestani A, Mahan G, Gardin J, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol. 1987;59:662-668.
17. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery disease. J Am Coll Cardiol. 1987;9:549-554.
18. Schillaci G, Verdecchia P, Borgioni C, et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol. 1994;74:714-719.
19. Aessopos A, Farmakis D, Taktikou H, Loukopoulos D. Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation. J Am Soc Echocardiogr. 2000;13:645-649.
20. Kanavakis E, Traeger-Synodinos J, Tzetis M, Metaxotou-Mavromati A, Ladis V, Kattamis C. Molecular characterization of homozygous (high HbA2) beta-thalassemia intermedia in Greece. Pediatr Hematol Oncol. 1995;12:37-45.
21. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe refractory anemia with hemochromatosis. Circulation. 1964;30:698-705.
22. Isner JM, Carter BL, Bankoff MS, Konstam MA, Salem DN. Computed tomography in the diagnosis of pericardial heart disease. Ann Intern Med. 1982;97:473-479.
23. Challenor VF, Conway N, Monro JL. The surgical treatment of restrictive cardiomyopathy in pseudoxanthoma elasticum. Br Heart J. 1988;59:266-269.
24. Aessopos A, Samarkos M, Voskaridou E, et al. Arterial calcifications in beta-thalassemia. Angiology. 1998;49:137-143.
25. Aessopos A, Savvides P, Stamatelos G, et al. Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia. Am J Hematol. 1992;41:159-164.
26. Aessopos A, Voskaridou E, Kavouklis E, et al. Angioid streaks in sickle-thalassemia. Am J Ophthalmol. 1994;117:589-592.
27. Tsomi K, Karagiorga-Lagana M, Fragodimitri C, Karabatsos F, Katsiki V. Arterial elastorrhexis: manifestation of a generalized connective tissue disorder in beta-thalassemia major. Eur J Haematol. 1999;63:287-294.
28. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral valve prolapse. N Engl J Med. 1982;307:228-231.
29. Jessup M, Manno CS. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci. 1998;850:242-250.
30. Lippman SM, Ginzton LE, Thigpen T, Tanaka KR, Laks MM. Mitral valve prolapse in sickle cell disease: presumptive evidence for a linked connective tissue disorder. Arch Intern Med. 1985;145:435-438.
31. Simmons BE, Santhanam V, Castaner A, Rao KR, Sachdev N, Cooper R. Sickle cell heart disease: two-dimensional and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia. Arch Intern Med. 1988;148:1526-1528.
32. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1-7.
33. Garnet ES, Goddard BA, Markby D, Webber CE. The spleen as an arteriovenous shunt. Lancet. 1969;1:386-388.
34. Soergel KH, Sommers SC. Idiopathic pulmonary hemosiderosis and related syndromes. Am J Med. 1962;32:499-511.
35. Cappellini MD, Coppola R, Robbiolo L, et al. Procoagulant activity of erythrocytes in thalassemia intermedia [abstract]. Blood. 1996;88(suppl 1):38.
36. O'Driscoll A, Mackie IJ, Porter JB, Machin SJ. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion. Br J Haematol. 1995;90:65-70.
37. Borgna-Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic event in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76-79.
38. Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992;23(suppl 2):25-28.
39. Grisaru D, Rachmilewitz E, Mosseri M, et al. Cardiopulmonary assessment in beta-thalassemia major. Chest. 1990;98:1138-1142.
40. Factor JM, Pottipati SR, Rappoport I, Rosner IK, Lesser ML, Giardina PJ. Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med. 1994;149:1570-1574.
41. Okura H, Takatsu Y. High-output heart failure as a cause of pulmonary hypertension. Intern Med. 1994;33:363-365.
42. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532-537.
43. Hajjar FM, Pearson HA. Pharmacologic treatment of thalassemia intermedia with hydroxyurea. J Pediatr. 1994;125:490-492.
44. Aessopos A, Farmakis D, Karagiorga M, Rombos I, Loucopoulos D. Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in beta-thalassemia patients. Stroke. 1997;28:2421-2424.